Literature DB >> 9779646

Laser treatment of solar elastosis with epithelial preservation.

J A Muccini1, F E O'Donnell, T Fuller, L Reinisch.   

Abstract

BACKGROUND AND
OBJECTIVE: Laser resurfacing has gained wide acceptance for the treatment of actinic facial skin. However, postoperative care of the face is reasonably complicated and prolonged erythema is common. To simplify the postoperative care and to possibly reduce the duration of the erythema, we investigated a laser treatment that spares the epithelium. STUDY DESIGN/
MATERIALS AND METHODS: A 980 nm diode laser was used with a spherical optic handpiece to focus the light in the dermis. We treated in vitro breast and facial skin and measured the tissue shrinkage and the histological changes. We also treated two patients and harvested the tissue after 6 and 21 days of wound healing.
RESULTS: The diode laser treatment does not ablate the epidermis. The tissue shows shrinkage (16% at 8W) similar to three passes of the scanned carbon dioxide laser treatment (15%). Thermal damage in the dermis is similar to the residual damage left after laser resurfacing with the scanned carbon dioxide laser. After 21 days the tissue shows new collagen and an abundance of young elastin fibers.
CONCLUSIONS: These investigations indicate that solar elastosis in skin can be treated with the 980 nm diode laser while preserving the epithelial layer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9779646     DOI: 10.1002/(sici)1096-9101(1998)23:3<121::aid-lsm1>3.0.co;2-r

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  2 in total

1.  Laser-assisted lipolysis in the treatment of gynecomastia: a prospective study in 28 patients.

Authors:  M A Trelles; S R Mordon; E Bonanad; J Moreno Moraga; A Heckmann; F Unglaub; N Betrouni; F M Leclère
Journal:  Lasers Med Sci       Date:  2012-02-19       Impact factor: 3.161

2.  Mathematical modeling of laser lipolysis.

Authors:  Serge R Mordon; Benjamin Wassmer; Jean Pascal Reynaud; Jaouad Zemmouri
Journal:  Biomed Eng Online       Date:  2008-02-29       Impact factor: 2.819

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.